Dr. Heidi D. Klepin, MD

Dr. Klepin practices at Davie Surgery - Ophthalmology - HOPD in Bermuda Run, North Carolina.

Dr. Klepin's NPI, 1275551228, was assigned on July 18, 2006. Dr. Klepin graduated from University of South Carolina School of Medicine in 1998. Dr. Klepin holds North Carolina license 2000-01183.

Dr. Klepin's primary practice is Davie Surgery - Ophthalmology - HOPD, at 329 Nc Highway 801 N, Bermuda Run, NC 27006.

Dr. Klepin's primary practice is Davie Surgery - Ophthalmology - HOPD in Bermuda Run, North Carolina. Dr. Klepin is also affiliated with Atrium Health Wake Forest Baptist Medical Center. The medical group on file is Atrium Health Wake Forest Baptist.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Klepin practices, 2 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Klepin's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Klepin is licensed in North Carolina.

CMS data shows 60 Medicare services from Dr. Klepin across 2 procedure codes in 2024, all of them office visits, for 69 Medicare patients. Medicare paid $5,173 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 69 Medicare patients who saw Dr. Klepin in 2024. The largest group is 75 to 84, with 27 patients. 75% of them have high blood pressure, and 74% have cancer. Their average risk score is 1.85, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Klepin's median patient age at 78, with 81% women.

In 2024, Dr. Klepin wrote 82 Medicare Part D claims for 33 patients. 94% of them were for generic drugs. CMS names the drug for 40 of them, across 1 drug with 11 or more claims each, at $671 in total drug cost. In 2023, CMS named 27 claims across 1 drug.

Dr. Klepin accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 175 papers to Dr. Klepin, published from 2006 to 2025. 2020 was the busiest year, with 20. The most frequent topics are Geriatric Assessment, Leukemia, Myeloid, Acute and Medical Oncology. Dr. Klepin has published most often in J Geriatr Oncol. Dr. Klepin's most frequent co-authors are Supriya Gupta Mohile, MD, Kah Poh Loh, MBCHB and Ajeet Gajra, MD.

Dmand AI links Dr. Klepin to 9 clinical trials, 3 of them phase 3 studies. 3 are still active or recruiting. Conditions studied include Breast Neoplasms, Fatigue and Breast Diseases. Wake Forest University Health Sciences sponsors the most, 5.

CMS Open Payments shows 13 general payments to Dr. Klepin from 4 drug and device companies from 2016 to 2022. Consulting fees make up the largest share, 54% of the total. Celgene Corporation paid the most, $3,952.

Dr. Klepin graduated from University of South Carolina School of Medicine in 1998.